SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indrayani Biotech Ltd

Industry : Diversified - Medium / Small

BSE Code

ISIN Demat

Book Value()

526445

INE007C01021

12.3260366

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

62.58

54.14

EPS(TTM)

Face Value()

Div & Yield %

0.19

Back

IIFL Capital Services consolidated net profit declines 58.84% in the September 2025 quarter

Nov 08,2025

Net profit of IIFL Capital Services declined 58.84% to Rs 84.41 crore in the quarter ended September 2025 as against Rs 205.06 crore during the previous quarter ended September 2024. Sales declined 11.36% to Rs 572.08 crore in the quarter ended September 2025 as against Rs 645.37 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	572.08	645.37	-11
OPM %	37.23	41.27	-
PBDT	134.98	276.89	-51
PBT	119.90	263.58	-55
NP	84.41	205.06	-59

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)